Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks

• Home
• Organization
  • Governance and By-Laws
  • Executive Committee
  • Oversight Committee
  • Consortia and Collaborations
  • Working Groups
• Meetings
  • ADEPT
    March 2011
  • ACTION-1
    June 2011
  • ACTTION-2
    October 2012
  • ACTTION-3
    June 2014
• Resources
  • Pain Database Standards
  • RReACT Database
  • RReADS Database
  • RReMIT Database
• Publications
• Partners
• IMMPACT
• Contact Us

September 13, 2016: ACTTION Receives Second 5-Year Cooperative Agreement from FDA

ACTTION is very pleased to announce that it has been awarded a second 5 years of funding from the FDA. The award is for up to a maximum of $4,000,000 to support ACTTION’s ongoing and planned efforts to expedite the discovery and development of improved analgesic, anesthetic, addiction, and peripheral neuropathy treatments for the benefit of the public health.